• Users Online: 387
  • Print this page
  • Email this page
Year : 1996  |  Volume : 1  |  Issue : 1  |  Page : 19-22

Intravesical adriamycin in the management of bladder tumours Enugu experience

Urology Unit Department of Surgery University of Nigeria Teaching Hospital, Enugu, Nigeria

Correspondence Address:
FRCS, FWACS Aloy E Aghaji
Dept. of Surgery, Enugu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Intravesical instillation of Adriamycin (Doxorubicin) was carried out in 30 patients with different stages of Bladder Tumours after fulguration, Transurethral Resection or open excision of the Tumour. The result in these patients was compared retrospectively with that of 30 patients with bladder tumour who had not received intravesical Chemotherapy. In the Adrimycin group, significantly more patients showed a decrease in recurrence rate of the bladder Tumour (77%) than in the control group (20%). This study shows that the use of adjuvant chemothereapy in the form of Intravesical Adriamycin is effective in reducing tumour recurrence.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal